Study directory

Bipolarity studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1909studies shown
Showing 1,009-1,020 of 1,909
Drug study icon
TerminatedNCT05169710

Investigational Drug for depression

This study was terminated in the United States, in Canada, in Bulgaria, .... It is testing investigational Drug for depression.

Multiple locations, including Huntsville
Why is this study shown?

This study includes Bipolarity among several conditions.

Depression, BipolarityDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, Canada, Bulgaria, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Depression, Bipolarity
Behavioral study icon
CompletedNCT02009371

A Clinical Study of Light Therapy on Depressive Episodes of Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Beijing
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionBehavioralFrom 18 Years to 65 Years
Countries
China
Sponsor
Peking University
Condition
Bipolarity, Depression
Drug study icon
TerminatedNCT05227209

Safety study of investigational Drug in depression

This study was terminated in the United States, in Bulgaria, and in Japan. It is testing investigational Drug for depression.

Multiple locations, including Huntsville
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States, Bulgaria, Japan
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00376220

A Placebo Controlled study of Riluzole in Depression in bipolarity

This study is completed in the United States. It is testing Double-Blind Placebo Controlled Trial of Riluzole for depression in bipolarity.

In Baltimore
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 75 Years
Countries
United States
Sponsor
Johns Hopkins University
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00232414

Quetiapine for depression

This study is completed in the United States. It is testing quetiapine for depression.

In Cincinnati
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 12 Years to 18 Years
Countries
United States
Sponsor
University of Cincinnati
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT01094249

Valproic Acid and Paliperidone Extended-Release (ER) for schizophrenia

This study is completed in the United States. It is testing Valproic Acid and Paliperidone Extended-Release (ER) for schizophrenia.

Multiple locations, including Kissimmee
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Bipolarity, Schizophrenia
Drug study icon
TerminatedNCT00535262

A Study Assessing EmSam in Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In New York
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Bipolarity, Depression
Behavioral study icon
CompletedNCT00377299

Citicoline add-on Therapy for depression

This study is completed in the United States. It is testing Citicoline add-on Therapy for depression.

In Dallas
Why is this study shown?

This study includes Bipolarity among several conditions.

Depression, BipolarityBehavioralFrom 18 Years to 70 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Depression, Bipolarity
Device study icon
CompletedNCT00699218

A Study on Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment of Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Davis
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 65 Years
Countries
United States
Sponsor
University of California, Davis
Condition
Bipolarity, Depression
Other study type icon
CompletedNCT04210804

A Prophylactic study of Omega-3 Polyunsaturated Fatty Acids in Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Galway
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionOtherOver 18 Years
Countries
Ireland
Sponsor
National University of Ireland, Galway, Ireland
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00844857

A Study for Assessing Treatment of Patients Ages 10-17 With Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including San Diego
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 10 Years to 17 Years
Countries
United States, Russia
Sponsor
Eli Lilly and Company
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.